Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer
Open Access
- 25 September 2021
- journal article
- research article
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2021, 1-5
- https://doi.org/10.1155/2021/2929233
Abstract
Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer: We investigated the diagnostic value of the tumor marker CA724 in patients with primary gastric cancer. One hundred forty-six patients with primary gastric cancer were selected as the observation group; 89 patients with gastritis treated in the same period were included in the control group 1; 91 patients with healthy physical examination during the same period were included in the control group 2. Electrochemiluminescence immunoassay was used to determine the level of carbohydrate antigen CA724 in each group; the pathological data of the observation group were consulted, and the expression level of tumor marker CA724 under different pathological conditions was analyzed; ROC curve was drawn to evaluate the diagnostic value of CA724 in gastric cancer and gastritis. The level of CA724 in primary gastric cancer patients was significantly correlated with tumor diameter, tumor stage, differentiation type, and lymph node metastasis. The ROC curve was drawn with a CA724 cutoff value of 7.94U/Ml. The AUC value of CA724 in primary gastric cancer patients was 0.815, with a diagnostic sensitivity of 84.68 and a specificity of 71.95. In conclusion, CA724 was highly expressed in patients with primary gastric cancer, which can achieve the diagnostic differentiation of gastric cancer and gastritis, and obtain a high diagnostic efficiency, providing a reference basis for clinical diagnosis and treatment.Keywords
Funding Information
- Shanghai Jiao Tong University (YG2016QN15)
This publication has 9 references indexed in Scilit:
- Serum phospholipids are potential biomarkers for the early diagnosis of gastric cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 2021
- CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapyBMC Cancer, 2021
- Correlation between tumor marker CA72-4 and prognosis of patients with gastric cancerMedicine, 2020
- Immunogenomic classification of gastric cancer based on the tumor microenvironments expression of PD-L1 and CD8+ T-cell infiltration.Journal of Clinical Oncology, 2020
- Observation of tumor-associated macrophages expression in gastric cancer and its clinical pathological relationshipMedicine, 2020
- Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations.Journal of Clinical Oncology, 2019
- Expression of CD44 and CD133 in tumor сells of metastatic and non-metastatic gastric cancer.Journal of Clinical Oncology, 2019
- Biomarkers of gastric cancer: Current topics and future perspectiveWorld Journal of Gastroenterology, 2018
- Preoperative hCGβ and CA 72‐4 are prognostic factors in gastric cancerInternational Journal of Cancer, 2004